Lipids and atherogenesis in diabetes mellitus.
Premature cardiovascular disease is a major burden in diabetes. Increasing cholesterol is associated with increasing vascular risk in diabetes and the absolute excess risk attributable to cholesterol is higher in diabetes than in non-diabetics. Total cholesterol and low density lipoprotein (LDL) cholesterol correlated with arterial endothelial dysfunction as assessed by reduced flow-mediated brachial artery dilatation in insulin-dependent diabetic patients. In non-insulin dependent diabetic patients hypertriglyceridaemia is common and is associated with the accumulation of intermediate density lipoproteins, abnormal postprandial lipid metabolism and small dense LDL. No trials of lipid lowering therapy in the primary or secondary prevention of cardiovascular disease have been targeted specifically to the diabetic population; nevertheless, guidelines have been published for the treatment of dyslipidaemia in diabetic patients recognising the evidence of benefit in non-diabetics and the high intrinsic risk of the diabetic.
Betteridge
D J
DJ
Department of Medicine, University College London Medical School, Middlesex Hospital, UK.
D003324:Coronary Artery Disease / Q000209:etiology* / Q000378:metabolism / Q000517:prevention & control; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000378:metabolism* / Q000628:therapy; D004730:Endothelium, Vascular / Q000378:metabolism; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000378:metabolism / Q000628:therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D050356:Lipid Metabolism; D012307:Risk Factors
D000960:Hypolipidemic Agents